acarix

Corporate Information, English, General meeting, IR, Listing Regulation, News, Notice, Regulatory

November 18, 2024

11 Apr 2022

Notice of Annual General Meeting in Acarix AB

Notice of Annual General Meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convene...

Continue reading

acarix

Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory

November 18, 2024

01 Apr 2022

FDA requests supplementary information for Acarix breakthrough designation request for heart failure diagnosis

Press release (MAR)Malmö, Sweden, April 1, 2022   FDA requests supplementary information for Acarix br...

Continue reading

acarix

Corporate Information, IR, MAR, News, Other Corporate Information, Regulatory, Swedish

November 18, 2024

01 Apr 2022

FDA begär kompletterande information för Acarix ansökan om Breakthrough Designation-status för diagnos av hjärtsvikt

Pressmeddelande (MAR)Malmö, Sverige, 1 april 2022   FDA begär kompletterande information för Acar...

Continue reading

acarix

Corporate Information, English, IR, MAR, News, Order, Regulatory, Sales

November 18, 2024

11 Mar 2022

Acarix receives strategic order for the CADScor®System in US

Press release (MAR)Malmö, Sweden, March 11, 2022   Acarix receives strategic order for the CADScor®System in U...

Continue reading

acarix

Corporate Information, IR, MAR, News, Order, Regulatory, Sales, Swedish

November 18, 2024

11 Mar 2022

Acarix erhåller strategisk order av CADScor®System i USA

Pressmeddelande (MAR)Malmö, 11 mars 2022   Acarix erhåller strategisk order av CADScor®System i USA Aca...

Continue reading

acarix

Corporate Information, English, IR, News, Other Corporate Information

November 18, 2024

10 Mar 2022

Acarix presents at the Redeye Artificial Intelligence Seminar 2022

Press release Malmö, Sweden, March 10, 2022   Acarix presents at the Redeye Artificial Intelligence Seminar 2022 ...

Continue reading

acarix

Corporate Information, IR, News, Other Corporate Information, Swedish

November 18, 2024

10 Mar 2022

Acarix presenterar vid Redeye seminarium om artificiell intelligens 2022

Pressmeddelande Malmö, 10 mars 2022   Acarix presenterar vid Redeye seminarium om artificiell intelligens 2022. D...

Continue reading

acarix

Corporate Information, IR, News, Other Corporate Information, Swedish

November 18, 2024

18 Feb 2022

Acarix kapitalmarknadsdag: Uppdatering kring strategi, marknader och målsättningar

Pressmeddelande Malmö, 18 februari 2022   Acarix kapitalmarknadsdag: Uppdatering kring strategi, marknader och m...

Continue reading

acarix

Corporate Information, IR, News, Other Corporate Information, Swedish

November 18, 2024

09 Feb 2022

Acarix lämnar in ansökan om status som Breakthrough Therapy till FDA vid diagnosen hjärtsvikt

Pressmeddelande Malmö, 9 februari 2022   Acarix lämnar in ansökan om status som Breakthrough Therapy til...

Continue reading

acarix

Corporate Information, English, IR, News, Other Corporate Information

November 18, 2024

09 Feb 2022

Acarix submits breakthrough designation request with FDA for heart failure diagnosis

Press release Malmö, Sweden, February 9, 2022   Acarix submits breakthrough designation request with FDA for heart...

Continue reading

acarix

Corporate Information, Financial calendar, IR, Listing Regulation, News, Regulatory, Swedish

November 18, 2024

09 Feb 2022

Acarix AB (publ) tidigarelägger publicering av delårsrapport för fjärde kvartalet till den 17 februari 2022

PressmeddelandeMalmö, 9 februari, 2022 Acarix AB (publ) tidigarelägger publicering av delårsrapport för fjär...

Continue reading

acarix

Corporate Information, English, Financial calendar, IR, Listing Regulation, News, Regulatory

November 18, 2024

09 Feb 2022

Acarix AB (publ) brings forward publication of interim report for fourth quarter to February 17, 2022

Press release Malmö, Sweden, February 9, 2022   Acarix AB (publ) brings forward publication of interim report for ...

Continue reading